Lundbeck poaches Zealand Pharma VP

Lundbeck has hired Trine Moulvad as senior vice president for its regulatory area. She joins the firm from a similar position at Zealand Pharma.

Trina Moulvad joins Lundbeck on June 20 | Photo: Lundbeck / PR

by andreas lønstrup, translated by daniel pedersen

Published: 06.05.22 at 10:38

Lundbeck has hired Trine Moulvad to lead the regulatory side of its business, the pharmaceutical firm informs MedWatch.

Her work at Lundbeck begins on June 20, when she will serve as senior vice president and head for regulatory, medical documentation & R&D quality.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

More from MedWatch

Long wait for IVDR implementation is over, putting an end to pandemic "wild west"

Photo: Thomas Borberg

After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.

GN purchase story is very speculative, says analyst

Foto: GN Store Nord / PR

Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.

Bavarian Nordic upgrades guidance following vaccine contract

Foto: Philip Davali/Ritzau Scanpix

Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.

Novo Nordisk invests additional millions of dollars in new manufacturing facilities

Foto: Novo Nordisk / PR

Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.

US to start using Bavarian vaccine stockpile

Photo: Lukas Barth/Reuters/Ritzau Scanpix

In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.

Further reading

Related articles